Lancashire and South Cumbria
Formulary
Formulary
9 Nutrition and blood
09-08-01 Wilsons disease
| Penicillamine |
|
Formulary
|
Tablets 125mg, 250mg |
 LSCMMG: Penicillamine shared care guideline |
|
Links
- LSCMMG shared care guideline - penicillamine
- LSCMMG: Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement
- LSCMMG: Gluten-Free food products: Position Statement
- LSCMMG: Oral Nutritional Supplements in Primary Care
- LSCMMG: Penicillamine shared care guideline
- LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children
- Medicines for children: Carnitine for metabolic disorders
- NICE CG32: Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
- NICE HST23 Asfotase alfa for treating paediatric-onset hypophosphatasia
- NICE HST25: Lumasiran for treating primary hyperoxaluria type 1
- NICE HST26 Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency
- NICE NG20: Coeliac disease: recognition, assessment and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE TA 915:Pegunigalsidase alfa for treating Fabry diease
- NICE TA1020: Eplontersen for treating hereditary transthyretin-related amyloidosis
- NICE TA821: Avalglucosidase alfa for treating Pompe disease
- NICE TA821: Avalglucosidase alfa for treating Pompe disease
- NICE TA868 Vutrisiran for treating hereditary transthyretin-related amyloidosis
- NICE TA868: Vutrisiran for treating hereditary transthyretin-related amyloidosis
- NICE TA915: Pegunigalsidase alfa for treating Fabry disease
- NICE: Asfotase alfa for treating paediatric-onset hypophosphatasia